Exponent, Inc. $EXPO Shares Sold by Geneva Capital Management LLC

Geneva Capital Management LLC reduced its stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 8.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,284,888 shares of the business services provider’s stock after selling 120,285 shares during the quarter. Exponent makes up approximately 2.4% of Geneva Capital Management LLC’s investment portfolio, making the stock its 14th largest position. Geneva Capital Management LLC’s holdings in Exponent were worth $84,057,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hantz Financial Services Inc. increased its stake in shares of Exponent by 9.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,857 shares of the business services provider’s stock worth $187,000 after acquiring an additional 253 shares during the last quarter. Russell Investments Group Ltd. boosted its position in shares of Exponent by 78.5% during the 3rd quarter. Russell Investments Group Ltd. now owns 28,013 shares of the business services provider’s stock valued at $1,833,000 after acquiring an additional 12,317 shares during the last quarter. Hohimer Wealth Management LLC acquired a new position in shares of Exponent during the 3rd quarter valued at about $221,000. Summit Creek Advisors LLC acquired a new position in shares of Exponent during the 3rd quarter valued at about $2,520,000. Finally, Chicago Partners Investment Group LLC purchased a new stake in shares of Exponent in the third quarter valued at about $226,000. 92.37% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Exponent

In other news, VP Richard Reiss sold 1,280 shares of Exponent stock in a transaction on Tuesday, November 3rd. The stock was sold at an average price of $86.44, for a total value of $110,643.20. Following the completion of the sale, the vice president directly owned 1,008 shares of the company’s stock, valued at approximately $87,131.52. The trade was a 55.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Exponent Price Performance

EXPO stock opened at $87.31 on Monday. The business has a fifty day moving average of $73.30 and a two-hundred day moving average of $67.23. The stock has a market cap of $4.15 billion, a price-to-earnings ratio of 37.63 and a beta of 0.66. Exponent, Inc. has a 52-week low of $51.91 and a 52-week high of $90.51.

Exponent (NASDAQ:EXPO – Get Free Report) last posted its earnings results on Thursday, October 29th. The business services provider reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.04. The company had revenue of $173.73 million for the quarter, compared to analysts’ expectations of $149.64 million. Exponent had a net margin of 17.40% and a return on equity of 34.61%. Exponent’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.55 earnings per share. As a group, sell-side analysts anticipate that Exponent, Inc. will post 2.36 EPS for the current year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, December 4th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, December 4th. Exponent’s dividend payout ratio (DPR) is currently 53.45%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on EXPO. Zacks Research upgraded shares of Exponent from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 2nd. JPMorgan Chase & Co. lifted their target price on shares of Exponent from $90.00 to $100.00 and gave the stock an “overweight” rating in a research note on Friday, October 30th. UBS Group boosted their target price on shares of Exponent from $72.00 to $82.00 and gave the company a “neutral” rating in a report on Friday, October 30th. Finally, Weiss Ratings raised shares of Exponent from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, November 9th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $91.00.

View Our Latest Research Report on Exponent

Exponent Profile

(Free Report)

Exponent, Inc. is a multidisciplinary engineering and scientific consulting firm that helps clients investigate complex technical issues and manage risk. Its consultants analyze incidents such as product failures and accidents, assess potential hazards, and provide expert advice on engineering, scientific, and regulatory matters. The company’s services span fields including engineering, materials science, environmental science, health, and data analytics. Clients use Exponent’s expertise for product development and testing, litigation support, regulatory compliance, and risk assessment across a range of industries.

Featured Stories

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.